Use of NK cell inhibition to facilitate persistence of engrafted MHC-I negative cells

Details for Australian Patent Application No. 2005331559 (hide)

Owner Regents of The University of Minnesota

Inventors Blazar, Bruce; Verfaillie, Catherine M.; Tolar, Jakub

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005331559

PCT Pub. Number WO2006/121428

Filing date 5 May 2005

Wipo publication date 16 November 2006

Acceptance publication date 19 April 2012

International Classifications

C12N 5/074 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Adult stem cells

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/121428 Priority application(s): WO2006/121428

19 April 2012 Application Accepted

  Published as AU-B-2005331559

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005331583-Ball suitable for water games

2005331550-Flexible independent multi-layer container and method for forming